DE3874741D1 - Immunassay-verfahren. - Google Patents

Immunassay-verfahren.

Info

Publication number
DE3874741D1
DE3874741D1 DE8888904993T DE3874741T DE3874741D1 DE 3874741 D1 DE3874741 D1 DE 3874741D1 DE 8888904993 T DE8888904993 T DE 8888904993T DE 3874741 T DE3874741 T DE 3874741T DE 3874741 D1 DE3874741 D1 DE 3874741D1
Authority
DE
Germany
Prior art keywords
antigen
labelled
immunassay
procedure
specimen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888904993T
Other languages
English (en)
Other versions
DE3874741T2 (de
Inventor
C O Walker Lab Ltd Walker
Roger Henry Casburn-Budd
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CAMBRIDGE LIFE SCIENCES
Original Assignee
CAMBRIDGE LIFE SCIENCES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26292330&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3874741(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB878713418A external-priority patent/GB8713418D0/en
Priority claimed from GB878714213A external-priority patent/GB8714213D0/en
Application filed by CAMBRIDGE LIFE SCIENCES filed Critical CAMBRIDGE LIFE SCIENCES
Publication of DE3874741D1 publication Critical patent/DE3874741D1/de
Application granted granted Critical
Publication of DE3874741T2 publication Critical patent/DE3874741T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE8888904993T 1987-06-09 1988-06-08 Immunassay-verfahren. Expired - Fee Related DE3874741T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB878713418A GB8713418D0 (en) 1987-06-09 1987-06-09 Assay
GB878714213A GB8714213D0 (en) 1987-06-17 1987-06-17 Assay
PCT/GB1988/000446 WO1988009933A1 (en) 1987-06-09 1988-06-08 Immunoassay method

Publications (2)

Publication Number Publication Date
DE3874741D1 true DE3874741D1 (de) 1992-10-22
DE3874741T2 DE3874741T2 (de) 1993-07-22

Family

ID=26292330

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888904993T Expired - Fee Related DE3874741T2 (de) 1987-06-09 1988-06-08 Immunassay-verfahren.

Country Status (5)

Country Link
EP (1) EP0366673B1 (de)
JP (1) JPH02503951A (de)
AT (1) ATE80740T1 (de)
DE (1) DE3874741T2 (de)
WO (1) WO1988009933A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164374A (en) * 1990-12-17 1992-11-17 Monsanto Company Use of oligosaccharides for treatment of arthritis
DE4430998A1 (de) * 1994-07-25 1996-02-01 Boehringer Mannheim Gmbh Metallchelat-markierte Peptide
JP3604147B2 (ja) 1994-07-25 2004-12-22 ロシュ ダイアグノスティックス ゲーエムベーハー 金属キレート標識ペプチド
CN1148578C (zh) 1994-07-25 2004-05-05 罗切诊断学有限公司 免疫测定特异抗体的方法、所用试剂、抗原及其用途
GB9719357D0 (en) * 1997-09-11 1997-11-12 Ortho Clinical Diagnostics Immunoassay Utilizing Two Incubations With Labelled Antigen
CA2406607C (en) 2000-04-26 2011-08-02 Land O'lakes, Inc. A method of treating soy proteins and a soy protein product produced by this method
GB0128583D0 (en) 2001-11-28 2002-01-23 Rsr Ltd Detection of autoantibodies indicative of diabetes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4189466A (en) * 1975-09-19 1980-02-19 Technical Research Affiliates, Inc. Detection of rheumatoid factor by antibody sensitized microbial particles
US4067959A (en) * 1976-05-10 1978-01-10 International Diagnostic Technology, Inc. Indirect solid surface test for antigens or antibodies
GB2029011B (en) * 1978-09-01 1983-02-02 Coulson W Use of a synthetic bifunctional ligand for the immunimetric determination of the concentration ratio of two solutes
GB2158578B (en) * 1984-05-08 1988-03-09 Farmos Group Ltd Immunometric method for the determination of a hapten
WO1986004993A1 (en) * 1985-02-26 1986-08-28 United States Of America, Represented By The Unite Detection of human t-cell leukemia virus type iii

Also Published As

Publication number Publication date
EP0366673B1 (de) 1992-09-16
EP0366673A1 (de) 1990-05-09
JPH02503951A (ja) 1990-11-15
WO1988009933A1 (en) 1988-12-15
ATE80740T1 (de) 1992-10-15
DE3874741T2 (de) 1993-07-22

Similar Documents

Publication Publication Date Title
SE7904386L (sv) Biologisk provmetod med utnyttjande av fast fas
DK212986D0 (da) Fremgangsmaade til bestemmelse af et stof i en proeve
DK343679A (da) Immunologisk fremgangsmaade til bestemmelse af et immunkompleks i en vaeske samt det ved frmegangsmaaden anvendte diagnostiske middel
FI905282A0 (fi) Anordning och foerfarande foer snabb kvalitativ och kvantitativ bestaemning av naervaron av en reaktiv ligand i ett fluidum.
ES2082777T3 (es) Un metodo para la deteccion de un anti-cuerpo y antigeno en un inmunoensayo.
SE7907535L (sv) Diagnostiskt forfarande
FI90799C (fi) Immunologisia määritysmenetelmiä ja niissä käytettävä reagenssi
ATE254286T1 (de) Zwei-inkubations mit markiertem antigen verwendenes immunoassay
NO843591L (no) Fremgangsmaate for aa bestemme pivka-ii-innhold i blodplasma og middel for utfoerelse av denne
DE3874741T2 (de) Immunassay-verfahren.
ES511156A0 (es) Un metodo de determinar la presencia de un antigeno en un medio liquido sospechoso de contenerlo.
ES2023868B3 (es) Procedimiento de determinacion inmunometrico
DE3685818T2 (de) Immunkomplextestverfahren.
DE3485265D1 (de) Verfahren zur bestimmung eines polyvalenten antigens und reagenz hierfuer.
EP0366092A3 (de) Verfahren zur Bestimmung von für ein Antigen klassenspezifischen Antikörpern und dazu geeignetes Reagenz
ATE50459T1 (de) Verfahren zur bestimmung einer immunologisch bindefaehigen substanz.
DE59109139D1 (de) Immunologischer Nachweis von Metolachlor
DE3273844D1 (en) Procedure for immunological determinations using two antibodies, the second antibody being purified by affinity chromatography, and supports therefor
ES8707798A1 (es) Un procedimiento para analizar una muestra de tejido para determinar la presencia de antigeno de la hepatitis no a no b
SE8304190D0 (sv) Forfarande och reagens for immunologiska metningar
ES546338A0 (es) Procedimiento para la determinacion de una sustancia capaz de fijarse inmunologicamente
ATE122150T1 (de) Einschritt-immuntest zur bestimmung von antigen- spezifischen antikörpern aller immunglobulin- klassen und dazu geeignetes mittel.
NO852058L (no) Fremgangsmaate og middel for bestemmelse av atl virus antistoffer.
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
ES2016992B3 (es) Reagente y procedimiento en la determinacion c 3a mediante ensayo inmunoquimico.

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee